GLAND PHARMA
|
GLAND PHARMA Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹1,063 Cr | ₹1,133 Cr | ₹1,055 Cr | ₹1,619 Cr | ₹1,335 Cr |
| Adjustment | ₹212 Cr | ₹224 Cr | ₹38 Cr | ₹-28 Cr | ₹17 Cr |
| Changes In working Capital | ₹-6.06 Cr | ₹-53 Cr | ₹-418 Cr | ₹-393 Cr | ₹-436 Cr |
| Cash Flow after changes in Working Capital | ₹1,269 Cr | ₹1,303 Cr | ₹675 Cr | ₹1,197 Cr | ₹916 Cr |
| Cash Flow from Operating Activities | ₹915 Cr | ₹997 Cr | ₹364 Cr | ₹791 Cr | ₹605 Cr |
| Cash Flow from Investing Activities | ₹1,705 Cr | ₹-1,757 Cr | ₹1,208 Cr | ₹-1,003 Cr | ₹-1,524 Cr |
| Cash Flow from Financing Activities | ₹-433 Cr | ₹-799 Cr | ₹15 Cr | ₹35 Cr | ₹1,238 Cr |
| Net Cash Inflow / Outflow | ₹2,186 Cr | ₹-1,560 Cr | ₹1,587 Cr | ₹-177 Cr | ₹319 Cr |
| Opening Cash & Cash Equivalents | ₹357 Cr | ₹1,909 Cr | ₹319 Cr | ₹492 Cr | ₹169 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | ₹13 Cr | ₹7.72 Cr | ₹3.00 Cr | ₹3.31 Cr | ₹3.58 Cr |
| Closing Cash & Cash Equivalent | ₹2,556 Cr | ₹357 Cr | ₹1,909 Cr | ₹319 Cr | ₹492 Cr |
Compare Cashflow Statement of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹27,682.3 Cr | -1.4% | -8.1% | -4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,513.0 Cr | -0.1% | 3.4% | -0.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,614.0 Cr | 1.6% | -2.5% | 8.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,245.0 Cr | 0.8% | -0.9% | 13.5% | Stock Analytics | |
| CIPLA | ₹122,555.0 Cr | 1.3% | -0.6% | 3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,803.0 Cr | 1% | 3.7% | 2.7% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -1.4% |
-8.1% |
-4% |
| SENSEX | -0.5% |
1% |
4.6% |
You may also like the below Video Courses